First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
26 janv. 2022 16h51 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s...
Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
25 janv. 2022 01h29 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
21 déc. 2021 19h49 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a clinical data access agreement with...
First Patient Dosed in Study of Targeted Alpha Therapy Candidate for Bladder Cancer
20 déc. 2021 16h45 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NANTES, France, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. (‘ATONCO’) today announce that...
FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
19 déc. 2021 16h47 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the development...
Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
07 déc. 2021 17h42 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and MADRID, Spain, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive...
Illuccix® recebe autorização de uso de imagens de câncer de próstata no Brasil
30 nov. 2021 19h30 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, Nov. 30, 2021 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX: TLX, Telix, a Empresa) anunciou hoje que a Agência Nacional de Vigilância...
Illuccix® Granted Use Authorisation for Prostate Cancer Imaging in Brazil
30 nov. 2021 16h45 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and PORTO ALEGRE, Brazil, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory...
NOBLE Study Brings Advanced Prostate Imaging to Rural Australia – First Patient Dosed
14 nov. 2021 15h59 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first Australian patient has been dosed in the...
Australian TGA Approves Illuccix® for Prostate Cancer Imaging
01 nov. 2021 19h25 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has...